Miriam H Meisler Selected Research

Miriam H Meisler Research Topics

Disease

20	Brain Diseases (Brain Disorder) 01/2021 - 10/2013
12	Epilepsy (Aura) 01/2021 - 01/2002
11	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020 - 09/2005
7	Seizures (Absence Seizure) 01/2021 - 03/2010
7	Nervous System Diseases (Neurological Disorders) 01/2019 - 09/2004
6	Channelopathies 04/2021 - 11/2008
5	Infantile Epileptic-Dyskinetic Encephalopathy 08/2018 - 05/2015
5	Generalized Epilepsy with Febrile Seizures Plus 03/2010 - 09/2005
3	Neurodevelopmental Disorders 04/2021 - 01/2021
3	Sudden Unexpected Death in Epilepsy 01/2021 - 01/2016
3	Absence Epilepsy (Childhood Absence Epilepsy) 05/2009 - 09/2005
2	Type 4j Charcot-Marie-Tooth Disease 01/2019 - 07/2011
2	Movement Disorders (Movement Disorder) 05/2016 - 01/2002
2	Intellectual Disability (Idiocy) 05/2015 - 10/2013
2	Muscle Weakness 09/2013 - 07/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2012 - 12/2009
2	Migraine with Aura (Familial Hemiplegic Migraine) 03/2010 - 11/2008
2	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 12/2009 - 08/2008
2	Ataxia (Dyssynergia) 11/2008 - 04/2003
2	Tremor (Tremors) 08/2008 - 07/2007
2	Generalized Epilepsy 10/2005 - 09/2005
2	Juvenile Myoclonic Epilepsy 10/2005 - 09/2005
2	Benign Neonatal Epilepsy (Benign Familial Neonatal Convulsions) 10/2005 - 09/2005
1	Apnea 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2021
1	Cognitive Dysfunction 01/2020
1	Hypopigmentation (Hypomelanosis) 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Sudden Death 01/2019
1	Myoclonus (Nocturnal Myoclonus) 01/2018
1	Body Weight (Weight, Body) 10/2017
1	Gliosis 02/2017
1	Cardiac Arrhythmias (Arrythmia) 11/2016
1	Leigh Disease (Leigh's Disease) 07/2016
1	Epileptic Syndromes 03/2014
1	Polymicrogyria 03/2014
1	Congenital Structural Myopathies (Centronuclear Myopathy) 09/2013
1	Febrile Seizures (Febrile Seizure) 03/2010
1	Infarction (Infarctions) 02/2009
1	Ischemia 02/2009
1	Chronic Pain 11/2008
1	Migraine Disorders (Migraine) 11/2008
1	Pain (Aches) 11/2008
1	Demyelinating Diseases (Demyelinating Disease) 08/2008
1	Partial Epilepsies (Epilepsy, Partial) 03/2008
1	Mental Disorders (Mental Disorder) 08/2005
1	Alzheimer Disease (Alzheimer's Disease) 10/2004
1	Polydactyly (Polydactylism) 06/2004

Drug/Important Bio-Agent (IBA)

24	Sodium Channels (Sodium Channel)IBA 01/2021 - 12/2003
14	Voltage-Gated Sodium ChannelsIBA 11/2019 - 01/2002
6	SodiumIBA 04/2021 - 11/2008
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 07/2011
3	phosphatidylinositol 3,5-diphosphateIBA 01/2019 - 07/2007
3	LipidsIBA 01/2019 - 12/2009
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 03/2008
3	P-2 (P 2)IBA 10/2012 - 08/2008
3	Ion Channels (Ion Channel)IBA 11/2008 - 09/2005
3	Calcium Channels (Calcium Channel)IBA 11/2008 - 09/2005
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2017
2	Antisense OligonucleotidesIBA 01/2021 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	Amino Acids FDA Link 05/2016 - 04/2003
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 09/2014
2	Proteins (Proteins, Gene)FDA Link 03/2012 - 08/2008
2	Potassium Channels (Potassium Channel)IBA 10/2005 - 09/2005
2	ChloridesIBA 10/2005 - 09/2005
2	EnzymesIBA 10/2005 - 09/2005
1	nusinersenIBA 01/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Pentylenetetrazole (Metrazol)IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	NestinIBA 01/2019
1	6- (4- (trifluoromethoxy)phenyl)- 3- (trifluoromethyl)(1,2,4)triazolo(4,3- a)pyridineIBA 01/2018
1	6- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA 10/2017
1	ConvulsantsIBA 02/2017
1	NeuropeptidesIBA 02/2017
1	RNA (Ribonucleic Acid)IBA 02/2017
1	antineoplaston A10 (A 10)IBA 11/2016
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2016
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2016
1	Mutant Proteins (Protein, Mutant)IBA 11/2014
1	Phosphoinositide PhosphatasesIBA 03/2014
1	Transcription Activator-Like Effector NucleasesIBA 02/2014
1	Tetrodotoxin (Tetradotoxin)IBA 01/2013
1	Flurothyl (Flurotyl)IBA 03/2010
1	Endothelin-1 (Endothelin 1)IBA 02/2009
1	beta CateninIBA 02/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2008
1	CalciumIBA 11/2008
1	voltage-dependent calcium channel (P-Q type)IBA 11/2008
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 03/2008
1	Carbamazepine (Tegretol)FDA LinkGeneric 03/2008
1	Lysosomal-Associated Membrane Protein 2IBA 07/2007
1	PresenilinsIBA 10/2004
1	Fumigant 93 (D-D)IBA 06/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 07/2013
2	Denervation 09/2013 - 07/2011
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021